Back to search
Adenoid Cystic Carcinoma of the Head and Neck
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Adenoid Cystic Carcinoma of the Head and Neck trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Adenoid Cystic Carcinoma of the Head and Neck trials you may qualify forThe ANTARES study is a phase II basket trial designed to evaluate the tissue-agnostic efficacy of the monoclonal anti-PD1 antibody, nivolumab, in patients with…
The goal of this observational study is to better understand why some people with metastatic adenoid cystic carcinoma (ACC) of the head and neck have slow-growi…
This pilot clinical trial studies transoral robotic surgery (TORS) in treating patients with benign or malignant tumors of the head and neck. TORS is a less inv…
This research study is studying the effect of different drugs as possible treatments for salivary and other head and neck cancers/ The name of the study interv…
This is a multicenter, open-label, Phase 1/2 study of orally administered VMD-928 monotherapy and in combination with pembrolizumab in adult subjects with advan…
RATIONALE: Collecting and storing samples of tissue, saliva, and blood from patients with cancer and from healthy participants to study in the laboratory may he…
This is an open-label, investigator-initiated phase II clinical trial designed to evaluate the efficacy and safety of Sacituzumab Tirumotecan (sac-TMT) monother…
This phase II trial studies the effect of pemetrexed and pembrolizumab in treating patients with salivary gland cancer that has come back (recurrent) and/or has…